Overview
Ingrid Meszoely is an Oncologist practicing medicine in Nashville, Tennessee.
Dr. Meszoely is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Triple-Negative Breast Cancer, Angiosarcoma, and Lymphadenectomy.
She is actively involved in clinical research, co-authoring 36 peer reviewed articles and participating in 2 clinical trials. Dr. Meszoely is currently accepting new patients.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
Locations
719 Thompson Ln Ste 25000, Nashville, TN 37204
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Tennessee Oncology, PLLC-#412 25th Ave
Ian Flinn is an Oncologist practicing medicine in Nashville, Tennessee. Dr. Flinn is highly rated in 39 conditions, according to our data. His clinical expertise encompasses Small Lymphocytic Lymphoma (SLL), Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Non-Hodgkin Lymphoma, and Bone Marrow Aspiration. Dr. Flinn is board certified in The American Board Of Internal Medicine - Hematology. Dr. Flinn is currently accepting new patients.
SCRI Oncology Partners
Erika Hamilton, MD, is an independent medical oncologist and hematologist at Ascension Saint Thomas in Nashville, Tennessee. Dr. Hamilton diagnoses and treats adults with cancer and focuses on managing care during and after chemotherapy, radiation therapy and surgery. Every appointment with Dr. Hamilton starts with a conversation. She takes the time to answer all your questions — big and small. Dr. Hamilton is highly rated in 24 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER2 Negative Breast Cancer, Ovarian Cancer, and HER-2 Positive Breast Cancer. Dr. Hamilton is board certified in The American Board Of Internal Medicine - Medical Oncology. Dr. Hamilton is currently accepting new patients.
Vanderbilt Breast Center
Ingrid Mayer is an Oncologist practicing medicine in Nashville, Tennessee. Dr. Mayer is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, PIK3CA-Related Overgrowth Spectrum, Triple-Negative Breast Cancer, and Angiosarcoma.
Frequently Asked Questions about Dr. Ingrid M. Meszoely
How do I make an appointment with Dr. Ingrid M. Meszoely?
You can book an appointment with Dr. Ingrid M. Meszoely by calling their office at 615-322-5000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Ingrid M. Meszoely a top-rated expert for Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ingrid M. Meszoely is classified as an Distinguished expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Ingrid M. Meszoely specialize in?
While Dr. Ingrid M. Meszoely is a Oncology, they have specific expertise in Breast Cancer, Paget Disease of the Breast, and Triple-Negative Breast Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Ingrid M. Meszoely participate in research or clinical trials?
Yes. Dr. Ingrid M. Meszoely has published 36 articles and abstracts on conditions like Breast Cancer. You can view a list of Dr. Ingrid M. Meszoely's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Ingrid M. Meszoely accept my insurance?
Dr. Ingrid M. Meszoely accepts most major insurance plans, including Alliant Health and Anthem BCBS. We recommend calling the office directly at 615-322-5000 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerDr. Meszoely isDistinguished. Learn about Breast Cancer.
- Paget Disease of the BreastDr. Meszoely isDistinguished. Learn about Paget Disease of the Breast.
- Advanced
- AngiosarcomaDr. Meszoely isAdvanced. Learn about Angiosarcoma.
- Triple-Negative Breast CancerDr. Meszoely isAdvanced. Learn about Triple-Negative Breast Cancer.
- Experienced
- BRCA Positive Breast CancerDr. Meszoely isExperienced. Learn about BRCA Positive Breast Cancer.
- Breast Cancer in MenDr. Meszoely isExperienced. Learn about Breast Cancer in Men.
- HER-2 Positive Breast CancerDr. Meszoely isExperienced. Learn about HER-2 Positive Breast Cancer.
- HER2 Negative Breast CancerDr. Meszoely isExperienced. Learn about HER2 Negative Breast Cancer.
- Inflammatory Breast CancerDr. Meszoely isExperienced. Learn about Inflammatory Breast Cancer.
- LymphadenectomyDr. Meszoely isExperienced. Learn about Lymphadenectomy.
- Lymphofollicular HyperplasiaDr. Meszoely isExperienced. Learn about Lymphofollicular Hyperplasia.
- PIK3CA-Related Overgrowth SpectrumDr. Meszoely isExperienced. Learn about PIK3CA-Related Overgrowth Spectrum.